0000874015-17-000004.txt : 20170104 0000874015-17-000004.hdr.sgml : 20170104 20170104183336 ACCESSION NUMBER: 0000874015-17-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170101 FILED AS OF DATE: 20170104 DATE AS OF CHANGE: 20170104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 FORMER COMPANY: FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HOUGEN ELIZABETH L CENTRAL INDEX KEY: 0001074773 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 17507776 MAIL ADDRESS: STREET 1: 10070 BARNES CANYON ROAD STREET 2: C/O MOLECULAR BIOSYSTEMS INC CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2017-01-01 0000874015 IONIS PHARMACEUTICALS INC IONS 0001074773 HOUGEN ELIZABETH L C/O IONIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010 0 1 0 0 SVP, Finance & CFO Common Stock 2017-01-01 2017-01-01 5 J 0 199 20.757 A 6747 D Employee Stock Option (right to buy) 47.34 2017-01-03 2017-01-03 4 A 0 45225 0 A 2018-01-03 2024-01-02 Common Stock 45225 45225 D Reporting 199 shares acquired under the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on January 1, 2017. These199 shares may not be sold until July 2, 2017. Grant of 1/3/2017 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan. 25% of the shares subject to the option vest and become exercisable on 1/3/2018. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 11,306 shares per year. Following this transaction, the option was exercisable as to 0 on 1/3/2017. /s/Elizabeth Hougen 2017-01-04